A detailed history of Alliancebernstein L.P. transactions in Axogen, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 55,330 shares of AXGN stock, worth $801,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,330
Previous 55,330 -0.0%
Holding current value
$801,178
Previous $400,000 93.75%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $42,751 - $60,772
7,540 Added 15.78%
55,330 $400,000
Q4 2023

Feb 14, 2024

SELL
$3.61 - $7.76 $7,328 - $15,752
-2,030 Reduced 4.07%
47,790 $326,000
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $13,057 - $25,835
2,790 Added 5.93%
49,820 $249,000
Q2 2023

Aug 15, 2023

BUY
$8.5 - $10.38 $10,455 - $12,767
1,230 Added 2.69%
47,030 $429,000
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $4,194 - $6,000
-600 Reduced 1.29%
45,800 $375,000
Q1 2022

May 13, 2022

BUY
$7.26 - $10.7 $726 - $1,070
100 Added 0.22%
46,400 $368,000
Q3 2021

Nov 10, 2021

SELL
$15.23 - $21.72 $15,230 - $21,720
-1,000 Reduced 2.11%
46,300 $732,000
Q2 2021

Jul 30, 2021

SELL
$17.8 - $23.5 $53,400 - $70,500
-3,000 Reduced 5.96%
47,300 $1.02 Million
Q1 2021

May 06, 2021

SELL
$17.18 - $22.6 $53,258 - $70,060
-3,100 Reduced 5.81%
50,300 $1.02 Million
Q4 2020

Feb 08, 2021

SELL
$11.5 - $17.96 $80,500 - $125,720
-7,000 Reduced 11.59%
53,400 $956,000
Q2 2020

Aug 13, 2020

BUY
$7.35 - $10.81 $72,030 - $105,938
9,800 Added 19.37%
60,400 $558,000
Q1 2020

May 14, 2020

BUY
$8.38 - $17.34 $56,146 - $116,178
6,700 Added 15.26%
50,600 $526,000
Q3 2019

Nov 14, 2019

SELL
$12.09 - $20.46 $105,183 - $178,002
-8,700 Reduced 16.54%
43,900 $548,000
Q2 2019

Aug 14, 2019

BUY
$18.5 - $25.47 $33,300 - $45,846
1,800 Added 3.54%
52,600 $1.04 Million
Q1 2019

May 14, 2019

SELL
$14.62 - $22.13 $23.5 Million - $35.6 Million
-1,607,970 Reduced 96.94%
50,800 $1.07 Million
Q4 2018

Feb 13, 2019

BUY
$17.09 - $38.25 $5.56 Million - $12.4 Million
325,460 Added 24.41%
1,658,770 $33.9 Million
Q3 2018

Nov 08, 2018

BUY
$34.05 - $55.9 $12.3 Million - $20.2 Million
361,090 Added 37.14%
1,333,310 $49.1 Million
Q2 2018

Aug 13, 2018

BUY
$36.15 - $52.5 $32.9 Million - $47.7 Million
909,470 Added 1449.35%
972,220 $48.9 Million
Q1 2018

May 14, 2018

BUY
$24.4 - $40.25 $745,420 - $1.23 Million
30,550 Added 94.88%
62,750 $2.29 Million
Q4 2017

Feb 13, 2018

BUY
$18.5 - $28.6 $246,050 - $380,380
13,300 Added 70.37%
32,200 $911,000
Q3 2017

Nov 13, 2017

BUY
$14.65 - $19.35 $276,885 - $365,715
18,900
18,900 $366,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $612M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.